President Donald Trump signed an executive order today moving marijuana out of the federal government’s most restrictive drug category, formally acknowledging that cannabis has medical value and a lower potential for abuse than previously recognized.
The order reclassifies marijuana from Schedule I, alongside heroin, to Schedule III, placing it in the same category as drugs like ketamine and testosterone. It also authorizes a new pilot program through the Centers for Medicare and Medicaid Services to reimburse certain cannabidiol, or CBD, treatments, including for cancer patients.
The move eases barriers to research and pharmaceutical development, but it does not legalize marijuana, does not change federal or state enforcement practices, and does not create legal retail access. For Virginia and Richmond, the announcement underscores a widening disconnect between federal policy signals and the state’s unresolved cannabis framework.
A federal shift, not legalization
Schedule III status makes it easier for universities, hospitals, and pharmaceutical companies to study cannabis and develop standardized cannabinoid-based medications. Researchers have long argued that Schedule I classification imposed unnecessary hurdles, even as medical cannabis programs expanded nationwide.
What the order does not do is legalize cannabis sales or protect existing businesses. Flower, edibles, and vape products remain illegal under federal law outside approved programs, and state laws still govern possession, sales, and enforcement.
Virginia’s unresolved contradiction
Virginia legalized adult possession of marijuana in 2021 but never implemented a legal retail system. Residents can legally possess cannabis, yet buying or selling it remains illegal. Lawmakers have failed for multiple sessions to agree on a regulated marketplace.
As RVA Magazine previously reported, the Joint Commission on the Future of Cannabis Sales has proposed a framework aimed at launching adult-use retail by November 2026. The plan includes a limited number of licenses, accelerated pathways for existing medical operators, and a set of “impact licenses” intended to prioritize applicants harmed by past cannabis enforcement or economic disinvestment.
That framework has drawn criticism from advocates and small operators who argue it prioritizes control and consolidation over access. With roughly 350 projected retail licenses statewide and high capital requirements, many fear the market will be dominated by well-funded companies while smaller entrepreneurs are shut out before sales even begin.
Federal rescheduling weakens one of the long-standing justifications for delay. Cannabis is no longer classified as having no medical use. The federal government has moved. Virginia has not.
Richmond’s enforcement reality
In Richmond, the gap between federal posture and state enforcement is already having real consequences.
While federal agencies prepare for expanded research and Medicare reimbursement tied to pharmaceutical-grade cannabinoid products, Virginia is actively cracking down on vape and hemp-derived cannabinoid retailers operating under state law.
A RVA Magazine interview posted this week with a Richmond-area vape shop owner detailed the impact of Virginia’s new vape law, which will make most currently sold vape and cannabinoid products illegal after December 31. Only products listed on a state-approved directory tied to federal authorization will remain legal, a list dominated by large tobacco-affiliated manufacturers.
“I don’t know how we stay open,” the owner told us, describing how CBD and hemp-derived products make up a core share of revenue for many independent shops.
Those enforcement efforts are unaffected by federal rescheduling. Schedule III status does not protect vape shops, hemp retailers, or small cannabis-adjacent businesses from fines, closures, or product bans.
Who benefits, and who waits
In the near term, the beneficiaries of rescheduling are researchers, hospitals, and pharmaceutical companies positioned to develop regulated cannabinoid treatments. Virginia institutions like VCU Health may see new opportunities as research barriers ease.
Small retailers, local entrepreneurs, and consumers see little immediate benefit. There are still no legal dispensaries. Licenses still cannot be issued. Enforcement continues. Meanwhile, parts of the existing retail ecosystem are being dismantled before a regulated cannabis market exists to replace it.
The larger pressure point
Taken together, federal rescheduling and Virginia’s regulatory stalemate reveal a system moving in opposite directions. Washington is acknowledging cannabis as legitimate medicine. Virginia is narrowing who can participate in cannabis-adjacent commerce and delaying the creation of a legal adult-use market.
The question facing Richmond and the Commonwealth is no longer whether cannabis has value. That question has been answered at the federal level. The remaining question is who gets to participate when legalization finally arrives, and how many small businesses will be left standing by then.
RELATED COVERAGE FROM RVA MAGAZINE
- Virginia’s Hemp Industry Faces New Threat from McConnell’s Amendment
- So You Want a Virginia Cannabis License? Read This First
- The Last of the Virginia Hemp Farmers
- Who Benefits from Virginia’s Cannabis Chaos? Small Businesses Want Answers
- Virginia’s Cannabis Battlefield: Big Players, Small Shops, and a Fight Over the Future
- 160 Years for Cannabis and Mushrooms: What Message Does Virginia Want to Send?
- How the Equity Fund Could Help More People Cultivate and Sell Cannabis
- Virginia Republicans Vote Against Bill to Establish Recreational Cannabis Retail Market
Support RVA Magazine. Support Independent Media in Richmond.
At a time when media ownership is increasingly concentrated among corporations and the wealthy, RVA Magazine has remained one of Richmond’s few independent voices. Since 2005, the magazine has provided grassroots coverage of the city’s artists, musicians, and communities, documenting the culture that defines Richmond beyond the headlines.
But we can’t do this without you. A small donation, even as little as $2, one-time or recurring, helps us continue to produce honest, local coverage free from outside interference. Every dollar makes a difference. Your support keeps us going and keeps RVA’s creative spirit alive. Thank you for standing with independent media. DONATE HERE.
We’ve got merch HERE
Subscribe to the Substack HERE
And Reddit HERE
And YouTube HERE
